Sign in →

Test ID BLOD5077 Inflammatory Bowel Disease Serology Panel, Serum

Reporting Name

Inflammatory Bowel Disease Panel, S

Useful For

As an adjunct in the diagnosis of ulcerative colitis and Crohn disease in patients suspected of having inflammatory bowel disease


Not useful to determine the extent of disease in patients with inflammatory bowel disease (IBD) or determine the response to disease-specific therapy including surgical resection of diseased intestine.

Profile Information

Test ID Reporting Name Available Separately Always Performed
AASCA Saccharomyces cerevisiae Ab, IgA, S Yes Yes
GASCA Saccharomyces cerevisiae Ab, IgG, S Yes Yes
NSA Neutrophil Specific Antibodies No Yes

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Specimen Type


Specimen Required


Preferred: Serum gel

Acceptable: Red top

Specimen Volume: 1 mL

Specimen Minimum Volume

0.8 mL

Specimen Stability Information

Specimen Type Temperature Time
Serum Refrigerated (preferred) 21 days
  Frozen  21 days

Reference Values

Saccharomyces cerevisiae ANTIBODY, IgA

Negative: ≤20.0 U

Equivocal: 20.1-24.9 U

Weakly positive: 25.0-34.9 U

Positive: ≥35.0 U


Saccharomyces cerevisiae ANTIBODY, IgG

Negative: ≤20.0 U

Equivocal: 20.1-24.9 U

Weakly positive: 25.0-34.9 U

Positive: ≥35.0 U



Negative (not detectable)

Day(s) and Time(s) Performed


Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Code Information


86671 x 2

Reject Due To


Mild OK; Gross reject


Mild OK; Gross reject


Mild OK; Gross OK



Method Name

AASCA, GASCA: Enzyme-Linked Immunosorbent Assay (ELISA)

NSA: Indirect Immunofluorescent Assay (IFA)


If not ordering electronically, complete, print, and send a Gastroenterology and Hepatology Client Test Request (T728) with the specimen.

Secondary ID